Robert W Fairbairn sold $209k of BSTZ
director at BlackRock Science & Technology Term Trust. 9,294 shares at an average of $22.51, traded Dec 18, 2025, filed Dec 22, 2025.
Score components
- +15RoleDirector
- +12Trade size$209k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-328961, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | SOpen-market sale Common Stock | -9,293 | $22.51 | $209k | 1 | Dec 22, 2025 |
| Dec 19, 2025 | SOpen-market sale Common Stock | -1 | $22.73 | $15 | 0 | Dec 22, 2025 |
Related signals
Other insiders at BlackRock Science & Technology Term Trust and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | BlackRock Science & Technology Term Trust | Stephen Thomas Minar Vice President | $20k 878 shares | +10% | |
| 43Moderate | BlackRock Science & Technology Term Trust | Tony Kim other | $920k 41,825 shares | +20% | |
| 29Weak | BSTZbuy BlackRock Science & Technology Term Trust | Tony Kim other | $501k 27,000 shares | +16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.